CELL-DENSITY-DEPENDENCE FOR GROWTH IN AGAROSE OF 2 HUMAN LYMPHOMA LINES AND ITS DECREASE AFTER EPSTEIN-BARR VIRUS CONVERSION

被引:27
作者
MONTAGNIER, L
GRUEST, J
机构
[1] Unité d'Oncologie Virale, Département de Virologie, Institut Pasteur, Paris
关键词
D O I
10.1002/ijc.2910230113
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have compared the growth in agarose medium of two EBV‐negative Burkitt lymphoma lines, BJAB and Ramos, and that of their EBV‐converted derivatives. Optimal conditions for growth in agarose medium are described. The original EBV‐negative lines can grow in agarose to a high efficiency, provided a critical level of cell concentration is attained. Below this level, there is no growth at all. EBV‐converted sublines form colonies at a much lower cell concentration, and their maximal plating efficiency is higher. These differences may be related to a super‐transformation state induced in these cells by EBV. Copyright © 1979 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:71 / 75
页数:5
相关论文
共 16 条
[1]   PRODUCTION BY EBV INFECTION OF AN EBNA-POSITIVE SUBLINE FROM AN EBNA-NEGATIVE HUMAN LYMPHOMA CELL LINE WITHOUT DETECTABLE EBV DNA [J].
CLEMENTS, GB ;
KLEIN, G ;
POVEY, S .
INTERNATIONAL JOURNAL OF CANCER, 1975, 16 (01) :125-133
[2]   ESTABLISHMENT OF EBNA-EXPRESSING CELL LINES BY INFECTION OF EPSTEIN-BARR VIRUS (EBV)-GENOME-NEGATIVE HUMAN LYMPHOMA-CELLS WITH DIFFERENT EBV STRAINS [J].
FRESEN, KO ;
ZURHAUSEN, H .
INTERNATIONAL JOURNAL OF CANCER, 1976, 17 (02) :161-166
[3]   BASIS OF TUMORIGENICITY OF BHK 21 CELLS [J].
JARRETT, O ;
MACPHERSON, I .
INTERNATIONAL JOURNAL OF CANCER, 1968, 3 (05) :654-+
[4]  
KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930
[5]   POLYOMA TRANSFORMATION OF HAMSTER CELL CLONES - INVESTIGATION OF GENETIC FACTORS AFFECTING CELL COMPETENCE [J].
MACPHERSON, I ;
STOKER, M .
VIROLOGY, 1962, 16 (02) :147-&
[6]  
MENEZES J, 1975, BIOMEDICINE, V22, P276
[7]  
MENEZES J, 1975, ONCOGENESIS HERPES 1, P323
[8]  
MONTAGNI.L, 1967, CR ACAD SCI D NAT, V265, P2161
[9]  
MONTAGNI.L, 1968, CR ACAD SCI D NAT, V267, P921
[10]  
MONTAGNIER L, 1966, JNCI-J NATL CANCER I, V36, P503